Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$26.14−0.21 (-0.80%)
Close on Nov 13, 2026Market cap $1.00BP/E –Yield –
Ceribell total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Ceribell's total debt was $19.98M at Jun 30, 2026. For fiscal 2025 it was $19.81M, up 1.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.81M | +1.3% |
| FY2024 | Dec 31, 2024 | $19.56M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.98M | +1.5% |
| Q1 FY2026 | Mar 31, 2026 | $19.92M | +1.5% |
| Q4 FY2025 | Dec 31, 2025 | $19.81M | +1.3% |
| Q3 FY2025 | Sep 30, 2025 | $19.75M | +1.3% |
| Q2 FY2025 | Jun 30, 2025 | $19.68M | – |
| Q1 FY2025 | Mar 31, 2025 | $19.62M | – |
| Q4 FY2024 | Dec 31, 2024 | $19.56M | – |
| Q3 FY2024 | Sep 30, 2024 | $19.50M | – |
See a number that looks wrong?